title: Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities.
abstract: In Brazil, scorpion envenomation is an important public health problem. The yellow scorpion, Tityus serrulatus (Ts), is considered the most dangerous species in the country, being responsible for the most severe clinical cases of envenomation. Currently, the administration of serum produced in horses is recognized and used as a treatment for accidents with scorpions. However, horse herds' maintenance is costly and the antibodies are heterologous, which can cause anaphylaxis and Serum Sickness. In the present work, a human monoclonal fragment antibody, Serrumab, has been analysed. Toxin neutralizing effects of Serrumab were evaluated using a two-electrode voltage-clamp technique. The results show that Serrumab presented a high neutralizing effect against Ts β-toxins (Ts1, 43.2% and Ts2, 68.8%) and none or low neutralizing effect against α-toxins (Ts3, 0% and Ts5, 10%). Additional experiments demonstrated that Serrumab was also able to neutralize the action of toxins from other scorpion genus (Css II, 45.96% and Lqh III, 100%/β- and α-toxins, respectively). This work indicated that Serrumab is able to neutralize many toxins in Ts venom, and could being considered as a neutralizing antibody for formulating a human anti-scorpion serum in Brazil. Additionally, this work demonstrated that Serrumab could neutralize different toxins from distinct scorpion genus. All these results reinforce the idea that Serrumab is a scFv antibody with multiple neutralizing capacities and a promising candidate for inclusion in scorpion anti-venoms against different genera.
authors.affiliation: Department of Biochemistry and Immunology, University of São Paulo at Ribeirão Preto School of Medicine , Ribeirão Preto, SP , Brazil .
authors.forename: Manuela Berto
authors.initials: MB
authors.lastname: Pucca
authors.forename: Felipe Augusto
authors.initials: FA
authors.lastname: Cerni
authors.forename: Steve
authors.initials: S
authors.lastname: Peigneur
authors.forename: Eliane Candiani
authors.initials: EC
authors.lastname: Arantes
authors.forename: Jan
authors.initials: J
authors.lastname: Tytgat
authors.forename: José Elpidio
authors.initials: JE
authors.lastname: Barbosa
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology*; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology*; D006801:Humans; D019476:Insect Proteins / Q000276:immunology; D009500:Neutralization Tests; D012604:Scorpion Venoms / Q000276:immunology*; D057127:Single-Chain Antibodies / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019476:Insect Proteins; D012604:Scorpion Venoms; D057127:Single-Chain Antibodies; C581453:Ts2 toxin, Tityus serrulatus; C485970:Ts3 toxin, Tityus serrulatus; C120263:scorpion toxin Ts1, Tityus; C000593859:serrumab